Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Blue, I agree with you that the reason Berlin didn't have the conference call is that an AXAL deal is likely in the works and there really wasn't anything he could say on a call without raising speculation. I don't think it makes sense to shut down our late stage Phase 3 trial, which is by far our most advanced construct. Berlin likely evaluated the company's business strategy and thought it wasn't smart for ADXS to carry the AXAL trials by ourselves for a construct that is a first generation while we are now focused on second generation. Like many of us said early on, O'Connor showed lacked of intelligence by ploughing forward full force alone on AXAL without seeking a monetary partner like Aduro did with JNJ under the misguided strategy of carry it as far alone as possible in order to get a bigger monetary deal on the back end (which has been proven flat out wrong). His mentality was it didn't matter because he was using other people's (our) money to fund it, while lining his own pockets on the way all while executing a strategy that was destined to destroy value. I think Berlin is making the right moves to turn around the company.